Arrowhead receives $100 million milestone from Sarepta for ARO-DM1 study
Go back to Arrowhead receives $100 million milestone from Sarepta for ARO-DM1 study| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 87.25 -1.99 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.24 | 52 Week High | $8.22 | |||
| Open | $89.09 | 52 Week Low | $3.07 | |||
| Day High | $90.61 | P/E | N/A | |||
| Day Low | $87.16 | EPS | $-1.30 | |||
| Volume | 1,119,664 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.38 +0.16 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.22 | 52 Week High | $63.73 | |||
| Open | $18.06 | 52 Week Low | $8.00 | |||
| Day High | $18.49 | P/E | N/A | |||
| Day Low | $17.86 | EPS | $-5.69 | |||
| Volume | 2,369,306 | |||||
